Jaime Feliú-Batlle

Serum interleukin-15 levels in cancer patients with cachexia.

P. Martínez-Hernández, C. Gómez-Candela, J. Castro-Carpeño, 2012, Oncology reports.

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

A. Gasbarrini, W. Li, H. Harputluoglu, 2023, The Lancet.